Egypt’s Competition Authority is set to issue a cease and desist order against a drug distributor that unlawfully limited supplies of a key IVF medication, marking the first time it has challenged such an infringement in the pharmaceutical sector.
To read more
Subscribe to Global Competition Review
Register for limited access
Register for free to unlock full access to our Insight content, including Guides, Reviews and Hubs. Plus, get our newsletter straight to your inbox.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now
